School of Medicine
Showing 501-600 of 856 Results
-
Himaja Nagireddy
Ph.D. Student in Health Policy, admitted Autumn 2025
BioHimaja Nagireddy (she/her) is a PhD student in Health Policy at Stanford. She previously served as a Program Manager at the Kennedy Krieger Institute, an affiliate of the Johns Hopkins School of Medicine, in Baltimore, MD.
Prior to this, Himaja served as the Deputy Associate Policy Director for First Lady Dr. Jill Biden at the White House, Briefings Manager for the Harris-Walz campaign, and Research Fellow at the CDC’s Agency for Toxic Substances and Disease Registry (ATSDR). She also served as the 11th Youth Observer to the UN from 2022-23. Himaja graduated with an MS in Environmental Epidemiology and a concentration in Infectious Disease Epidemiology from the Harvard T.H. Chan School of Public Health in 2022, and her bachelor’s degrees in Physiology and Neurobiology, Molecular and Cell Biology, and Sociology from the University of Connecticut in 2020. -
Hoang Minh Hieu Nguyen
MD Student with Scholarly Concentration in Molecular Basis of Medicine / Surgery, expected graduation Spring 2030
BioHoang Minh Hieu Nguyen, from Di Linh, Vietnam, is pursuing an MD at Stanford School of Medicine. They earned a bachelor’s degree in neuroscience from Middlebury College and a master of philosophy in clinical neurosciences from the University of Cambridge. Hieu aspires to combine science, the arts, and entrepreneurship to improve healthcare quality and access for global populations burdened by chronic disease. Hieu has contributed to advancing our understanding of cancer and neurodegenerative diseases through research at Middlebury College, Rockefeller University, Memorial Sloan Kettering Cancer Center, University of Cambridge, and Dana-Farber Cancer Institute. As a Social Entrepreneurship Fellow at Middlebury, they collaborated with the Kenyan Ministry of Health and the World Telehealth Initiative to establish Kenya’s first telemedicine system. This program provides lifesaving services, including dialysis, to Longisa, where such services were once unreachable.
-
Chloe Nobuhara
Masters Student in Epidemiology and Clinical Research, admitted Autumn 2025
BioDr. Chloe Nobuhara is a Stanford general surgery resident and AI researcher dedicated to upholding patient safety standards while pursing aggressive surgical innovation. Currently on a two-year professional development track during residency, her research explores the intersection of AI and surgical practice. She has collaborated with the Medical AI and Computer Vision (MARVL) Lab to use computer vision and vision language models for performance assessment, worked with the Operating Room Black Box technologies for ambient intelligence and automated documentation, and most recently is helping to organize a foreign body identification challenge for MICCAI.
Dr. Nobuhara holds an MD from Duke University and an undergraduate degree from Northeastern University. Originally hailing from Honolulu, Hawaii, she brings a global perspective to her work, having flown over 100,000 miles (4x around the globe) for speaking engagements and conferences during her research time. -
Peter Nonso Nwokoye
MD Student with Scholarly Concentration in Bioengineering, expected graduation Spring 2028
BioPeter Nonso Nwokoye was born and raised in Nigeria and graduated summa cum laude with dual Bachelor of Science degrees in Chemistry and Biology from Barry University. During his undergraduate studies, he worked on the synthesis of selective muscarinic receptor agonists and antagonists. In 2021, he was awarded the prestigious Gates Cambridge Scholarship to study at King's College, University of Cambridge. There, under the mentorship of Professor Anthony Davenport, he researched the expression and signaling of the apelin receptor and its endogenous agonists, Elabela and Apelin, in glioblastoma stem cells. This experience sparked his interest in developing novel methods to deorphanize orphan Class A GPCRs. After several months of intensive computational research, Peter developed a complex, multi-layered bioinformatic tool that he has used to identify likely endogenous ligands of orphan GPCRs, focusing on peptide ligands found in annotated uncharacterized open reading frames in the human genome. In his free time, he enjoys soccer, running, meditating, and teaching. Peter is excited about pursuing a career as a physician-scientist.
-
Marcus Oehlrich, PhD
Masters Student in Biomedical Data Science, admitted Autumn 2025
BioI am a Professor of Finance, Accounting, and Taxation at accadis University of Applied Sciences in Bad Homburg, Germany, and I advise on startups, business valuation, and corporate finance. My consulting projects range from small startups in biotechnology and M&A transactions in the pharmaceutical and biotech sectors to the preparation of the business plan for the IPO of an international music and movie production group.
During my business studies, I became interested in law and medicine (especially cancer research), which is why I continued my education in these fields (including a Master of Science in Pharmaceutical Medicine, a Certificate in Pharmaceutical Law, and an MPH at Harvard T.H. Chan School of Public Health). Subsequently, I have started the M.S. in Biomedical Data Science at the Department of Biomedical Data Science at Stanford University School of Medicine.
I also had the privilege of serving as the CEO of the Institute for German, European, and International Medical Law, Health Law, and Bioethics of the Universities of Heidelberg and Mannheim (IMGB) from 2005 to 2011. At accadis University of Applied Sciences, I am Head of the Health Care Management Research Group and responsible for the Master of Arts in International Health Care Management. From 2010 to 2020, I served as the Honorary Consul of the Republic of San Marino in Frankfurt, Germany.
Most of my publications (12 books and more than 70 articles) are related to business topics. However, I also authored three books on cancer "Internetkompass Krebs [Internet compass cancer]" (Springer 2001), "Recombinant humanized monoclonal antibody Trastuzumab for the treatment of metastatic breast cancer with tumors overexpressing the HER2/neu proto-oncogene: A systematic review" (dissertation.de 2003) and "Krebs vorbeugen und bekämpfen [Preventing and combating cancer: All about prevention, early detection, therapy]" (Reader's Digest 2012). The latter was translated into Polish, Czech, Croatian, Slovenian, and Hungarian. -
Jackson Powell
MD Student, expected graduation Spring 2029
Ph.D. Student in Bioengineering, admitted Autumn 2026
MSTP StudentCurrent Research and Scholarly InterestsI am broadly interested in brain-computer interfaces. This includes reading neural activity through clinical means like intracranial EEG, or lab methods like Neuropixels. Similarly, I am interested in neuromodulation, such as deep brain stimulation for neurosurgical patients, or optogenetics for discovery.
-
Johnny G. Powell
MD Student with Scholarly Concentration in Community Health, expected graduation Spring 2028
MBA, expected graduation 2028BioJohnny Powell, from Greensboro, North Carolina, is pursuing an MD at Stanford School of Medicine as a Knight-Hennessy Scholar. He graduated cum laude from Harvard University with a bachelor’s degree in chemistry and a minor in psychology. Johnny aspires to lead medical practice in underserved communities and drive structural change to make health care more accessible at scale. While at Harvard, he led youth mentorship programming in Boston and Japan, conducted research in the natural and social sciences, and shadowed hospital physicians in Spain. As president of the Harvard Black Men’s Forum, Johnny implemented lasting infrastructure to promote public service and inclusion. After graduating, he worked as an associate consultant at Bain & Company on health care and social impact projects. Passionate about health equity, Johnny also served as research coordinator for the All of Us Research Program, a national National Institutes of Health initiative to increase diversity in health care research, at the University of Chicago.
-
Jessica Pullen
MD Student with Scholarly Concentration in Biomedical Ethics & Medical Humanities
Current Research and Scholarly InterestsIn collaboration with Dr. Meera Sankar, Medical Director of LPCH NICU and President-Elect of the California Association of Neonatologists, we are exploring the implications of implementing Transcutaneous versus serum measurements of Bilirubin for diagnosis and management of Hyperbilirubinemia. We are particularly interested in patient care benefits, cost/benefit analyses as well as implications for global health settings.
